IE 11 is a very old browser and is not supported on this site.

Remuneration awarded for 2025 and 2024

Remuneration awarded to the Board of Directors for 2025 and 2024

Comments to the remuneration tables of the members of the Board of Directors

In the reporting year, the Board of Directors consisted of seven members. The total remuneration awarded to the Board of Directors (including the Board Chair) for 2025 amounts to CHF 1.6 million and is within the amount of CHF 1.9 million approved at the Annual General Meeting in 2024. It corresponds to an increase of 1.8% compared to the previous year. The remuneration system remained unchanged compared to the previous year.

Remuneration awarded to the CEO and the members of the Corporate Executive Committee for 2025 and 2024

Comments to the remuneration tables of the members of the Corporate Executive Committee

In the reporting year, Marc Werner (CEO), was the member of the Corporate Executive Committee with the highest remuneration.

The remuneration awarded to the CEO and the Corporate Executive Committee for 2025 amounts to CHF 7.0 million and is within the amount of CHF 9.5 million approved at the Annual General Meeting in 2024. It is an increase compared to the previous year, for the following reasons:

Performance in 2025

In the reporting year, the Galenica Group generated consolidated net sales of CHF 4,135.6 million. This corresponds to strong growth of 5.5% compared to the previous year.

Adjusted¹ operating profit (EBIT), i.e., excluding the effects of the accounting standards IFRS 16 (leasing), IAS 19 (employee benefits), IFRS 3 (amortisation of acquired intangible assets) and one-off effects, increased by 11.3% to CHF 234.8 million. Adjusted¹ return on sales (ROS) increased year-on-year from 5.4% to 5.7%.

Adjusted¹ net profit increased by 3.0% to CHF 188.7 million (previous year: CHF 183.2 million). Reported net profit was above the previous year's level at CHF 183.9 million (previous year: CHF 183.7 million, +0.1%).

1) See section Alternative performance measures in the Annual Report 2025.

Remuneration of the Board of Directors for 2025 and shareholdings at 31.12.2025

 

Remuneration

Number of shares

Payments in thousand CHF

Fees in cash

Equivalent in shares 1)

Other remuneration 2)

Total

Held as at 31.12.2025 3)

Allocated for 2025

Markus R. Neuhaus, Chair

467

37

504

16,300

4,963

Pascale Bruderer 4)

200

21

221

6,680

2,127

Nadine Balkanyi-Nordmann (since 11 April 2025)

120

13

133

125

1,276

Bertrand Jungo 4)

80

107

22

209

9,516

1,134

Judith Meier 4)

160

17

177

5,805

1,702

Solange Peters

60

80

17

157

1,809

851

Jörg Zulauf

187

14

201

4,921

1,985

Remuneration of the members of the Board of Directors 5)

140

1,320

142

1,602

45,156

14,038

Maximum amount according to AGM resolution

1,900

 

 

1) The amounts include the calculated discount of 25%, granted due to the five-year blocking period

2) Other remuneration corresponds to the social security charges (both employer and employee contributions)

3) Shares held by related parties of members of the Board of Directors are included in the declaration of the totals disclosed above

4) Those board members participate in the pension fund and finance the entire cost themselves

5) See chapter Board of Directors of the Corporate Governance section for roles and membership of committees

Remuneration of the Board of Directors for 2024 and shareholdings at 31.12.2024

 

Remuneration

Number of shares

Payments in thousand CHF

Fees in cash

Equivalent in shares 1)

Other remuneration 2)

Total

Held as at 31.12.2024 3)

Allocated for 2024

Markus R. Neuhaus, Chair

175

233

38

446

13,181

3,119

Pascale Bruderer 4)

75

100

20

195

5,343

1,337

Bertrand Jungo 4)

80

107

21

208

9,866

1,426

Judith Meier 4)

160

16

176

3,666

2,139

Solange Peters

60

80

16

156

739

1,070

Andreas Walde (died on 11 December 2024)

173

18

191

18,750

2,317

Jörg Zulauf

187

14

201

2,125

2,496

Remuneration of the members of the Board of Directors 5)

390

1,040

143

1,573

53,670

13,904

Maximum amount according to AGM resolution

1,900

 

 

1) The amounts include the calculated discount of 25%, granted due to the five-year blocking period

2) Other remuneration corresponds to the social security charges (both employer and employee contributions)

3) Shares held by related parties of members of the Board of Directors are included in the declaration of the totals disclosed above

4) Those board members participate in the pension fund and finance the entire cost themselves

5) See chapter Board of Directors of the Corporate Governance section for roles and membership of committees

Remuneration of the Corporate Executive Committee for 2025

Gross payments in thousand CHF

Total

of which Marc Werner, CEO

Base salary

2,993

540

Short-term bonus in cash (STI) 1)

1,281

277

Short-term bonus in shares (STI) 2)

803

173

Long-term incentive (LTI) 3)

818

250

Contributions to pension funds

568

127

Other remuneration 4)

93

13

Remuneration awarded

6,556

1,380

Social security costs

460

89

Remuneration of the members of the Corporate Executive Committee

7,016

1,469

Maximum amount according to AGM resolution

9,500

 

Nine members in 2025

1) The short-term bonus for the reporting year, which is paid out in the following year

2) The amounts include the calculated discount of 25% granted due to the five-year blocking period

3) Performance share units falling due after three years are included with the fair value at allocation

4) Including private use of company car

Remuneration of the Corporate Executive Committee for 2024

Gross payments in thousand CHF

Total

of which Marc Werner, CEO

Base salary

2,777

500

Short-term bonus in cash (STI) 1)

985

216

Short-term bonus in shares (STI) 2)

618

136

Long-term incentive (LTI) 3)

746

225

Contributions to pension funds

552

118

Other remuneration 4)

74

12

Remuneration awarded

5,752

1,207

Social security costs

407

79

Remuneration of the members of the Corporate Executive Committee 5)

6,159

1,286

Maximum amount according to AGM resolution

8,500

 

Nine members in 2024

1) The short-term bonus for the reporting year, which is paid out in the following year

2) The amounts include the calculated discount of 25% granted due to the five-year blocking period

3) Performance share units falling due after three years are included with the fair value at allocation

4) Including private use of company car

5) Including remuneration of Stephan Mignot since 1 September 2024 as Chief Pharmacies Marketing

Short-term incentive (STI)

In the reporting year, a GEP of CHF 74.0 million was achieved. This corresponds to an increase of 14.3% compared to the previous year, see Value based management section, under Alternative performance measures in the Annual Report 2025. This represents a payout factor of 176.8% for the portion of the STI payout based on GEP performance.

The Group annual net sales growth achieved was 5.5%, corresponding to a payout factor of 142.5% for that portion of the STI.

ESG performance was measured using two objectives: Net Promoter Score (NPS) and employee motivation rate. The payout factor for the NPS component amounts to 78.8%. The employee motivation rate achieved 78.0 points, corresponding to a payout factor of 133.3%.

Consequently, the overall STI payout for the CEO and the other members of the Corporate Executive Committee for the reporting year amounts to 150.5%. This compares to a payout of 127.3% for the previous year.

Performance / payout factor under STI in 2025

KPIs

2025 objectives

Payout

Target

2025 results

Group financial performance:

 

 

 

 

Galenica economic profit (GEP) (50% weighting)

Maximum

220%

CHF 78.3 million

GEP achieved: CHF 74.0 million Payout factor: 176.8%

Target

100%

CHF 66.3 million

Threshold

50%

CHF 56.3 million

Group annual net sales growth (25% weighting)

Maximum

220%

+8.6%

Net sales growth achieved: 5.5% Payout factor: 142.5%

Target

100%

+3.8%

Threshold

50%

-0.2%

Net Promoter Score (NPS) (12.5% weighting)

Maximum

150%

not disclosed for competition reasons

Payout factor: 78.8%

Target

100%

Threshold

50%

Employee motivation rate (12.5% weighting)

Maximum

150%

79 points

Employee motivation rate achieved: 78 points Payout factor: 133.3%

Target

100%

76 points

Threshold

50%

73 points

Payout

 

 

 

2025

CEO

 

 

 

150.5%

Corporate Executive Committee (without CEO)

 

 

 

150.5%

Long-term incentive (LTI)

For the LTI plan 2023-2025, payable in early 2026, the average GEP achievement was CHF 62.6 million. This represents a vesting multiple of 59.4%.

For relative TSR Galenica achieved an average percentile ranking of 73.6%, corresponding to a vesting multiple of 148.0%.

Consequently, the overall vesting level for the CEO and the other members of the Corporate Executive Committee for the LTI plan 2023-2025 amounts to 103.7%. This compares to a vesting level of 123.0% for the LTI plan 2022-2024.

KPIs

2025 objectives

Payout

Target

2025 results

Group financial performance:

 

 

 

 

Galenica economic profit (GEP) (50% weighting)

Maximum

200%

CHF 90.7 million

Average GEP achieved: CHF 62.6 million Vesting multiple: 59.4%

Target

100%

CHF 70.7 million

Threshold

50%

CHF 50.7 million

Relative TSR (50% weighting)

Maximum

200%

best in the peer group

Relative TSR achieved: average percentile ranking of 73.6% Vesting multiple: 148.0%

Target

100%

Median ranking

Threshold

50%

25th percentile ranking

Total LTI 2023-2025

 

 

 

Vesting multiple: 103.7%

Galenica uses cookies to optimise the functions of the website and to ensure you enjoy the best possible experience. Use of cookies & disclaimer